↓ Skip to main content

The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, July 2019
Altmetric Badge

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens
Published in
Journal of Experimental & Clinical Cancer Research, July 2019
DOI 10.1186/s13046-019-1282-0
Pubmed ID
Authors

Yi-Ying Wu, Hung-Chang Wu, Jia-En Wu, Kuo-Yen Huang, Shuenn-Chen Yang, Si-Xuan Chen, Chao-Jung Tsao, Keng-Fu Hsu, Yuh-Ling Chen, Tse-Ming Hong

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 24%
Researcher 8 19%
Student > Bachelor 6 14%
Student > Master 3 7%
Professor 2 5%
Other 2 5%
Unknown 11 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 14 33%
Medicine and Dentistry 6 14%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Agricultural and Biological Sciences 2 5%
Unspecified 1 2%
Other 3 7%
Unknown 13 31%